Literature DB >> 3027816

Ultimate survival from septic shock.

G Azimi, J L Vincent.   

Abstract

Detailed hemodynamic course during prolonged (less than 12 h) septic shock was studied in 23 patients, of whom 12 ultimately died from sepsis. Hemodynamic presentation was similar in fatalities and in survivors, except for a higher heart rate and a markedly higher blood lactate in fatalities (8.4 +/- 1.4 vs. 3.7 +/- 0.4 mEq/l, P less than 0.01). During fluid resuscitation, the pulmonary artery occlusive pressure associated with the highest left ventricular stroke work was usually around 17 mmHg, but in some patients above 20 mmHg. During the course of septic shock, left ventricular function improved in both fatalities and survivors, so that an altered cardiac function had no ultimate pejorative implication. The higher blood lactate in the absence of a different hemodynamic pattern tends to indicate that peripheral distributive defect remains the essential anomaly in septic shock. Arterial lactate appears to represent the most reliable indicator of ultimate prognosis in septic shock.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3027816     DOI: 10.1016/0300-9572(86)90068-7

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  17 in total

1.  Heart rate as an independent risk factor in patients with multiple organ dysfunction: a prospective, observational study.

Authors:  Robert S Hoke; Ursula Müller-Werdan; Christine Lautenschläger; Karl Werdan; Henning Ebelt
Journal:  Clin Res Cardiol       Date:  2011-11-03       Impact factor: 5.460

2.  Heart rate reduction with esmolol is associated with improved arterial elastance in patients with septic shock: a prospective observational study.

Authors:  A Morelli; M Singer; V M Ranieri; A D'Egidio; L Mascia; A Orecchioni; F Piscioneri; F Guarracino; E Greco; M Peruzzi; G Biondi-Zoccai; G Frati; S M Romano
Journal:  Intensive Care Med       Date:  2016-04-21       Impact factor: 17.440

3.  Right ventricular function in septic shock.

Authors:  C Reuse; N Frank; B Contempré; J L Vincent
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

4.  Chemical monitoring of intensive care patients using intravenous microdialysis.

Authors:  H Stjernström; T Karlsson; U Ungerstedt; L Hillered
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

5.  Respective impact of lowering body temperature and heart rate on mortality in septic shock: mediation analysis of a randomized trial.

Authors:  Frédérique Schortgen; Anaïs Charles-Nelson; Lila Bouadma; Geoffray Bizouard; Laurent Brochard; Sandrine Katsahian
Journal:  Intensive Care Med       Date:  2015-07-23       Impact factor: 17.440

Review 6.  Pathophysiology of sepsis-related cardiac dysfunction: driven by inflammation, energy mismanagement, or both?

Authors:  Konstantinos Drosatos; Anastasios Lymperopoulos; Peter Johannes Kennel; Nina Pollak; P Christian Schulze; Ira J Goldberg
Journal:  Curr Heart Fail Rep       Date:  2015-04

7.  Blood pressure and arterial lactate level are early indicators of short-term survival in human septic shock.

Authors:  G Bernardin; C Pradier; F Tiger; P Deloffre; M Mattei
Journal:  Intensive Care Med       Date:  1996-01       Impact factor: 17.440

8.  Relative Bradycardia in Patients With Septic Shock Requiring Vasopressor Therapy.

Authors:  Sarah J Beesley; Emily L Wilson; Michael J Lanspa; Colin K Grissom; Sajid Shahul; Daniel Talmor; Samuel M Brown
Journal:  Crit Care Med       Date:  2017-02       Impact factor: 7.598

Review 9.  The autonomic nervous system in septic shock and its role as a future therapeutic target: a narrative review.

Authors:  Marta Carrara; Manuela Ferrario; Bernardo Bollen Pinto; Antoine Herpain
Journal:  Ann Intensive Care       Date:  2021-05-17       Impact factor: 6.925

Review 10.  Sepsis-induced cardiomyopathy.

Authors:  Francisco J Romero-Bermejo; Manuel Ruiz-Bailen; Julian Gil-Cebrian; Maria J Huertos-Ranchal
Journal:  Curr Cardiol Rev       Date:  2011-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.